Sotac Pharmaceuticals Ltd.
SOTAC.NS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.23B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.23 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $0.20 |
| Dividend yield | 0.18% |
| Earnings per Share | $- |
| Beta | -0.02 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Sotac Pharmaceuticals Ltd.
127 employees
CEO: Sharadkumar D. Patel
Sotac Pharmaceuticals Ltd. is an India-based company operating within the pharmaceutical industry, specializing in the manufacturing of a diverse range of pharmaceutical formulations. The company functions primarily as a Contract Develop...